Hutch News
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
August 26, 2019
Fred Hutch at ASCO: HPV vaccine uptake in U.S., immunotherapy and sarcoma, financial toxicity of cancer, health care disparities and more
The American Society of Clinical Oncology will hold its annual meeting May 31-June 4 in Chicago
Aiming to reduce the risk for venous thromboembolism
From the Lyman Group, Divisions of Public Health Sciences and Clinical Research
Blood clots: What cancer patients need to know
A common side effect of cancer and its treatment gets renewed attention and potential new therapies
Dr. Veena Shankaran joins leadership of Fred Hutch’s health care economics and policy research institute
She will contribute to strategic planning, scientific priority setting, fundraising and organizational development
ASCO endorses integrative oncology guidelines for breast cancer patients
Yoga, meditation, acupuncture and more can be safely used to relieve side effects of standard treatment
Fred Hutch at ASCO
Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering
At half the cost, Canadian colorectal cancer survival similar to that of U.S.
Cross-border collaboration compared findings in British Columbia and Washington state
Biologics and biosimilars step onto the cancer therapy stage
Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?
Fred Hutch, Microsoft partner to improve cancer care delivery
Project to flag treatment-related symptoms early is revealed at Seattle conference
Hutch health economics releases first public report on cancer care quality and cost
Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration
New guidelines take aim at chemo-related nausea
Cancer patients ‘should not be vomiting with chemo anymore.’ Can someone please tell Hollywood?
Surviving cancer without going broke
HICOR’s Value in Cancer Care Summit tackles skyrocketing costs, financial toxicity, balancing cost with the right care and more
Key stories of Fred Hutch research from 2016
A roundup of some of our favorite 2016 stories on research at Fred Hutch
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
The sexual aftermath of cancer treatment
From impotence to ‘chemopause’ to missing body parts, treatment side effects can mess with patients’ sex lives — why don’t we talk about it more?
Fred Hutch medical tipsheet for July
Cancer moonshot, research, global health, HIV vaccine, health care policy story ideas and more
Big takeaways from ASCO cancer conference: immunotherapy, precision medicine and more
Immunotherapy, precision medicine and patient-powered research among the highlights of the world’s largest cancer conference
Forgotten patients: New guidelines help those with head-and-neck cancers
Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that
Collaborating to boost value-based care
HICOR hammers out solutions, addresses hard questions on cost and cancer care at third annual summit
6 questions in cancer immunotherapy
From cancer vaccines to engineered T cells, experts weigh in on the big unknowns
‘Future of oncology’: New playbook for precision medicine
Fred Hutch researcher helps lay crucial groundwork for precision medicine, improved patient care
Commentary: Oncologist speaks out on human toll of high health care costs
A Fred Hutch researcher speaks out on the human cost of the ‘unfettered, unbridled greed’ within our health care system